# Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program

> **NIH NIH T32** · UNIVERSITY OF CINCINNATI · 2022 · $489,120

## Abstract

Project Summary (Abstract)
This is a proposal to fund a new Post Graduate Hematology/Oncology Translational (PG-HOT) training
program led by Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati
College of Medicine. The rationale for this new T32 is rooted in the recent acceleration of basic research and
clinical cancer investigation at University of Cincinnati over the past decade. Starting with relatively modest
beginnings, we now have a sufficient critical mass of funded investigators and their complementary graduate
and postgraduate trainees to justify the investment of NCI resources into moving our cancer effort to the next
level. In that context, we have carefully analyzed our strengths and weaknesses, along with a perusal of existing
training programs sponsored by the NCI, and have structured our proposal to both build on our strengths
and fill a certain gap in the existing programs. The PG-HOT training program will have the following
participating departments: Internal Medicine, Cancer Biology, Pediatrics, and Pharmacology and Systems
Physiology. We request support for 3 postdoctoral trainees (PhD or PhD/MD) and 1 clinical fellow (MD or
MD/PhD). PG-HOT’s main objective is to generate a cadre of cancer researchers uniquely trained to rapidly
translate new discoveries into cancer patient care. The overarching rationale synergizes with the “Moonshot”
initiative. The specific goals are: (1) To provide formal and integrated instruction on the role of intellectual
property protection in drug development in the context of a complex economy that is both market-based and
government-regulated. (2) To provide a comprehensive didactic and practical training in anti-cancer compound
evaluation, with a primary focus on rigorous training in how to conceptualize, design, manage, and successfully
carry to completion a clinical trial involving a novel drug. (3) To establish a collaborative structure that promotes
genuinely creative and productive interactions between PhD scientists and MD-MD/PhD clinicians. Our effort
will center on training junior investigators to be effective collaborators in their subsequent careers in academia,
industry, or clinical care. These goals will be achieved by recruitment of high-quality applicants including
underrepresented minorities, mentorship by nationally and internationally renowned scientists, support by our
research-intensive Division and several basic-science departments, well-funded institutional programs and
centers, and input from distinguished and enthusiastic members of Internal and External Advisory Boards.

## Key facts

- **NIH application ID:** 10433906
- **Project number:** 5T32CA236764-04
- **Recipient organization:** UNIVERSITY OF CINCINNATI
- **Principal Investigator:** VLADIMIR BOGDANOV
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $489,120
- **Award type:** 5
- **Project period:** 2019-07-05 → 2024-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10433906

## Citation

> US National Institutes of Health, RePORTER application 10433906, Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program (5T32CA236764-04). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10433906. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*